Canopy Growth Corporation (CGC)
Nasdaq · Healthcare · Drug Manufacturers - Specialty & Generic
$0.8845+1.04%as of Oct 6, 2026, 4:35 AM ET
- Market cap
- $397M
- 52-week range
- $0.844 – $2.38
- 52-week change
- −37.05%
- EPS (trailing)
- −$0.45
- Next earnings
- Nov 6, 2026
Fiscal year to Mar 2026
- Net income
- −$189M
From the company’s annual report on SEC EDGAR.
About Canopy Growth Corporation
Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and cannabis-related products for medical and adult use in Canada, Germany, the United States, and internationally. The company operates through two segments, Cannabis and Storz & Bickel. It also provides vaporizers and accessories; dried flower and pre-rolled joints, oil, and vapes and beverages; extracts and concentrates, such as softgel capsules; and cannabis edibles, including gummies. In addition, the company operates e-commerce shop; medical cannabis online distribution platform; and an online medical cannabis clinic. It sells its products under the Tweed, 7ACRES, Deep Space, HiWay, Maitri, Twd., Spectrum Therapeutics, Canopy Medical, Abba Medix, Storz & Bickel, Wana, and Claybourne, Apollo, Canada House, R'belle, LowKey, MTL Cannabis, DeeLish, DOJA brands. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation is headquartered in Smiths Falls, Canada.
Headquarters: Smiths Falls, Canada · 1,128 employees · canopygrowth.com